Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7356)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2016 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Na GH, Hong TH, You YK, Kim DG. Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation. World J Gastroenterol 2016; 22(25): 5790-5799 [PMID: 27433092 DOI: 10.3748/wjg.v22.i25.5790] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i25/5790.htm |
| Number | Citing Articles |
| 1 |
Aline L. Chagas, Guilherme E.G. Felga, Marcio A. Diniz, Renato F. Silva, Angelo A. Mattos, Rita C.M.A. Silva, Ilka F.S.F. Boin, José H.P. Garcia, Agnaldo S. Lima, Julio C.U. Coelho, Paulo L. Bittencourt, Venâncio A.F. Alves, Luiz A.C. D’Albuquerque, Flair J. Carrilho. Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study: clinical profile and prognostic factors of survival. European Journal of Gastroenterology & Hepatology 2019; 31(9): 1148 doi: 10.1097/MEG.0000000000001448
|
| 2 |
Dong‐Hwan Jung, Eunyoung Tak, Shin Hwang, Gi‐Won Song, Chul‐Soo Ahn, Ki‐Hun Kim, Deok‐Bog Moon, Tae‐Yong Ha, Gil‐Chun Park, Baek‐Yeol Ryoo, Kyung Jin Lee, Nayoung Kim, Jae‐Hyeon Kwon, Eun‐Kyoung Jwa, Sung‐Gyu Lee. Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence. Liver Transplantation 2018; 24(7): 932 doi: 10.1002/lt.25191
|
| 3 |
Tae Yun Lee, Ho Joong Choi, Joseph Ahn, Tae Ho Hong, Young-Kyoung You. Efficacy of Tumor Markers After Liver Transplantation In Patients With Hepatocellular Carcinoma. Transplantation Proceedings 2022; 54(2): 461 doi: 10.1016/j.transproceed.2022.01.007
|
| 4 |
Alexander E Giakoustidis, Dimitrios E Giakoustidis. Immunosuppression Strategies in Liver Transplantation Patient; Patients with Hepatocellular Carcinoma. Immunotherapy 2017; 9(2): 197 doi: 10.2217/imt-2016-0110
|
| 5 |
Sami Akbulut, Murat Tamer, Serdar Saritas, Ozlem Unal, Musap Akyuz, Selver Unsal, Zeynep Kucukakcali, Ertugrul Karabulut, Sertac Usta, Sezai Yilmaz. Immunosuppressive Medication Adherence in Patients With Hepatocellular Cancer Who Have Undergo Liver Transplantation: A Case Control Study. Transplantation Proceedings 2023; 55(5): 1231 doi: 10.1016/j.transproceed.2023.02.064
|
| 6 |
Min-Jae Kim, Shin Hwang, Gi-Won Song, Deok-Bog Moon, Dong-Hwan Jung, Chul-Soo Ahn, Tae-Yong Ha, Gil-Chun Park. Seven-year survival after peritoneal metastasis of hepatocellular carcinoma occurring 12 years after living donor liver transplantation. Annals of Liver Transplantation 2023; 3(1): 23 doi: 10.52604/alt.23.0005
|
| 7 |
Christopher Buros, Atman Ashwin Dave, Alessandro Furlan. Immediate and Late Complications After Liver Transplantation. Radiologic Clinics of North America 2023; 61(5): 785 doi: 10.1016/j.rcl.2023.04.002
|
| 8 |
Yang Zhao, Yu Liu, Lin Zhou, Guo-Sheng Du, Qiang He. Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2021; 13(9): 953-966 doi: 10.4240/wjgs.v13.i9.953
|
| 9 |
Elizabeth V. Craig, Matthew T. Heller. Complications of liver transplant. Abdominal Radiology 2021; 46(1): 43 doi: 10.1007/s00261-019-02340-5
|
| 10 |
Abdulahad Al-Ameri, Xiaobo Yu, Shusen Zheng. Predictors of post-recurrence survival in hepatocellular carcinoma patients following liver transplantation: Systematic review and meta-analysis. Transplantation Reviews 2022; 36(1): 100676 doi: 10.1016/j.trre.2021.100676
|
| 11 |
Francesco Tovoli, Dante Pio Pallotta, Vito Sansone, Massimo Iavarone, Massimo De Giorgio, Luca Ielasi, Giovan Giuseppe Di Costanzo, Paolo Giuffrida, Rodolfo Sacco, Tiziana Pressiani, Maria Francesca Di Donato, Franco Trevisani, Stefano Fagiuoli, Fabio Piscaglia, Alessandro Granito. Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments. Transplantation 2023; 107(1): 156 doi: 10.1097/TP.0000000000004271
|
| 12 |
Reimi Suzuki, Ryoichi Goto, Norio Kawamura, Masaaki Watanabe, Yoshikazu Ganchiku, Kanako C Hatanaka, Yutaka Hatanaka, Toshiya Kamiyama, Tsuyoshi Shimamura, Akinobu Taketomi. Efficient multiple treatments including molecular targeting agents in a case of recurrent hepatocellular carcinoma, post-living donor liver transplantation. Clinical Journal of Gastroenterology 2022; 15(4): 755 doi: 10.1007/s12328-022-01643-3
|
| 13 |
Jaesung Heo, O. Kyu Noh, Young-Taek Oh, Mison Chun, Logyoung Kim. Second primary cancer after liver transplantation in hepatocellular carcinoma: a nationwide population-based study. Hepatology International 2017; 11(6): 523 doi: 10.1007/s12072-017-9824-z
|
| 14 |
Abdulwahab A Alshahrani, Shin Hwang, Gi-Won Song, Deok-Bog Moon, Dong-Hwan Jung, Chul-Soo Ahn, Ki-Hun Kim, Tae-Yong Ha, Gil-Chun Park, Su-Min Ha, Yo-Han Park, Sung-Gyu Lee. Management of very late peritoneal metastasis of hepatocellular carcinoma 10 years after liver transplantation: Lessons from two cases. Annals of Hepato-Biliary-Pancreatic Surgery 2018; 22(2): 136 doi: 10.14701/ahbps.2018.22.2.136
|
| 15 |
Anthony T. Tan, Sophia Schreiber. Adoptive T-cell therapy for HBV-associated HCC and HBV infection. Antiviral Research 2020; 176: 104748 doi: 10.1016/j.antiviral.2020.104748
|
| 16 |
A. Bauschke, A. Altendorf-Hofmann, H. Kissler, A. Koch, C. Malessa, U. Settmacher. Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation. Journal of Cancer Research and Clinical Oncology 2017; 143(12): 2595 doi: 10.1007/s00432-017-2507-2
|
| 17 |
S Dueland, A Foss, J M Solheim, M Hagness, P-D Line. Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma. British Journal of Surgery 2018; 105(6): 736 doi: 10.1002/bjs.10769
|
| 18 |
Jing Zhang, Guanya Guo, Tao Li, Changcun Guo, Ying Han, Xinmin Zhou. Early versus Late Recurrence of Hepatocellular Carcinoma after Microwave Ablation: Patterns, Treatments, and Post-Recurrence Survival. Oncology 2024; 102(9): 785 doi: 10.1159/000536542
|